Iceland-based Alvotech and the US unit of Israel’s of Teva Pharmaceutical Industries today revealed that that the US Food and ...

Datwyler said its new NeoFlex plunger components support drug integrity, reliable dosing and effective machinability.

The drug is approved for multiple inflammatory conditions and is expected to launch in the first half of 2025.

The FDA has approved Imuldosa, a biosimilar to Stelara (ustekinumab), for the treatment of various chronic inflammatory diseases.

The Food and Drug Administration (FDA) has approved Imuldosa ™ (ustekinumab-srlf), a biosimilar to Stelara ® (ustekinumab), for the treatment of various chronic inflammatory diseases. Imuldosa, ...

At issue here is a county government’s contention — despite scientific evidence to the contrary — that needle exchange ...

The global Intradermal Injection Market is expected to exceed an impressive valuation of USD 3,878 Million in 2022, with a ...

Richard Lowenthal is the President and Chief Executive Officer of ARS Pharmaceuticals, holds a case for its product Neffy in ...

The crisis of homelessness is pushing American psychiatry to places it has not gone before — like sidewalk injections of ...

The injectable vitamins produced by Nebraska-based STASKA Pharmaceuticals were distributed to health-care providers nationwide.

Beverly Tchang, MD, an endocrinologist and obesity specialist at Weill Cornell Medicine in New York City, instructs some of ...